• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《COVID-19 大流行一年回顾:我们已知的和未知的》——综述

One Year of the COVID-19 Pandemic. What Do We Know and What Is Yet to Come? - The Summarising Review.

机构信息

Department of Family Medicine, Wroclaw Medical University, Wroclaw, Poland.

Department of Pharmacognosy and Herbal Medicines, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Int J Public Health. 2021 Jul 30;66:1603975. doi: 10.3389/ijph.2021.1603975. eCollection 2021.

DOI:10.3389/ijph.2021.1603975
PMID:34588946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8475762/
Abstract

The aim of this review is to summarize the most relevant scientific discoveries regarding SARS- CoV-2 virus infection, with the special emphasis put on its pathophysiology and way of treatment. In November 2020, the research articles have been collected and examined manually to pick the most relevant. In case of fresh topics, e.g. vaccines, we have performed searching using adequate keywords. Preliminary analysis was conducted on 200 manuscripts. Among them 59 papers were out-of-scope, and thus were rejected from the further elaboration. Another 25 papers were rebuffed because they presented topics, that have been extensively described in the already included papers. Basing on the 29 papers we have estimated ratio of observed SARS-CoV-2 infection clinical manifestations and comorbidities among hospitalized patients. 12 papers let us evaluate frequencies of deviations within laboratory markers concentrations, as well as weighted average of the laboratory tests results. Due to the significant infectivity of the virus and its harmfulness towards organism further studies are required to find accurate way of the disease treatment and suspending its spreading.

摘要

本文旨在总结与 SARS-CoV-2 病毒感染相关的最重要的科学发现,特别强调其病理生理学和治疗方法。2020 年 11 月,我们通过手动收集和检查研究文章,以挑选出最相关的文章。对于新的主题,例如疫苗,我们使用了适当的关键字进行搜索。我们对 200 篇手稿进行了初步分析。其中 59 篇文章不在研究范围内,因此被排除在进一步阐述之外。另外 25 篇文章被拒绝,因为它们所提出的主题已经在已包含的文章中进行了广泛描述。基于这 29 篇文章,我们评估了住院患者中观察到的 SARS-CoV-2 感染临床表现和合并症的比例。有 12 篇文章让我们评估了实验室标志物浓度内偏差的频率,以及实验室检测结果的加权平均值。由于该病毒的高传染性及其对机体的危害性,需要进一步研究以找到准确的疾病治疗方法并阻止其传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb6f/8475762/063a11da7091/ijph-66-1603975-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb6f/8475762/6d3643032799/ijph-66-1603975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb6f/8475762/063a11da7091/ijph-66-1603975-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb6f/8475762/6d3643032799/ijph-66-1603975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb6f/8475762/063a11da7091/ijph-66-1603975-g002.jpg

相似文献

1
One Year of the COVID-19 Pandemic. What Do We Know and What Is Yet to Come? - The Summarising Review.《COVID-19 大流行一年回顾:我们已知的和未知的》——综述
Int J Public Health. 2021 Jul 30;66:1603975. doi: 10.3389/ijph.2021.1603975. eCollection 2021.
2
Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis.新冠疫情后的疤痕:COVID-19 后纤维化的文献计量分析。
Front Public Health. 2022 Sep 20;10:967829. doi: 10.3389/fpubh.2022.967829. eCollection 2022.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
A Reminder of Skin Cancer During the COVID-19 Pandemic.新冠疫情期间对皮肤癌的提醒。
Acta Dermatovenerol Croat. 2021 Apr;291(1):58.
5
The smoker's paradox during the COVID-19 pandemic? The influence of smoking and vaping on the incidence and course of SARS-CoV-2 virus infection as well as possibility of using nicotine in the treatment of COVID-19 - Review of the literature.新冠疫情期间的“烟民悖论”?吸烟和电子烟对 SARS-CoV-2 病毒感染的发生率和病程的影响,以及尼古丁在 COVID-19 治疗中的应用可能性——文献综述。
Przegl Epidemiol. 2021;75(1):27-44. doi: 10.32394/pe.75.03.
6
COVID-19 pandemic as reflected in Advances in Clinical and Experimental Medicine.在《临床与实验医学进展》中反映的 COVID-19 大流行。
Adv Clin Exp Med. 2022 Dec;31(12):1305-1307. doi: 10.17219/acem/157447.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
9
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
10
Atypical Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: A Systematic Review.儿童严重急性呼吸综合征冠状病毒2感染的非典型表现:一项系统综述
Curr Pediatr Rev. 2021;17(3):162-171. doi: 10.2174/1573396317666210406153302.

引用本文的文献

1
"Why would we?" A qualitative study on COVID-19 vaccination decision making among Ukrainian economic female migrants in Poland.为什么要这样做?波兰的乌克兰经济女性移民对 COVID-19 疫苗接种决策的定性研究。
Front Public Health. 2024 Aug 13;12:1380627. doi: 10.3389/fpubh.2024.1380627. eCollection 2024.
2
Effect of COVID-19 vaccination on the timing and flow of menstrual periods in two cohorts.2项队列研究中新冠病毒疫苗接种对月经周期时间和经量的影响
Front Reprod Health. 2022 Jul 25;4:952976. doi: 10.3389/frph.2022.952976. eCollection 2022.
3
COVID-19 Vaccination and Ukrainian Refugees in Poland during Russian-Ukrainian War-Narrative Review.

本文引用的文献

1
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.单剂 Ad26.COV2.S 疫苗预防新冠病毒的安全性和有效性。
N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.
2
Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.IL-6 水平升高预示 COVID-19 预后不良:呼吁使用托珠单抗和恢复期血浆治疗。
Front Immunol. 2021 Mar 4;12:598799. doi: 10.3389/fimmu.2021.598799. eCollection 2021.
3
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
俄乌战争期间波兰的新冠疫苗接种与乌克兰难民——叙述性综述
Vaccines (Basel). 2022 Jun 16;10(6):955. doi: 10.3390/vaccines10060955.
4
Assessment of Attitudes, Main Concerns and Sources of Knowledge Regarding COVID-19 Vaccination in Poland in the Unvaccinated Individuals-A Nationwide Survey.波兰未接种新冠疫苗人群对新冠疫苗接种的态度、主要担忧及知识来源评估——一项全国性调查
Vaccines (Basel). 2022 Mar 2;10(3):381. doi: 10.3390/vaccines10030381.
mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
4
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.肝素抑制 SARS-CoV-2 的细胞侵袭:刺突 S1 受体结合域与肝素相互作用的结构依赖性。
Thromb Haemost. 2020 Dec;120(12):1700-1715. doi: 10.1055/s-0040-1721319. Epub 2020 Dec 23.
5
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗(阿斯利康)对 SARS-CoV-2 的安全性和有效性:巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
7
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
8
An aberrant STAT pathway is central to COVID-19.异常的 STAT 通路是 COVID-19 的核心。
Cell Death Differ. 2020 Dec;27(12):3209-3225. doi: 10.1038/s41418-020-00633-7. Epub 2020 Oct 9.
9
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
10
Convalescent plasma therapy in patients with COVID-19.COVID-19 患者的恢复期血浆疗法。
Transfus Apher Sci. 2021 Feb;60(1):102955. doi: 10.1016/j.transci.2020.102955. Epub 2020 Sep 19.